Shuttle Pharmaceuticals Holdings (SHPH) Change in Cash (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Change in Cash of $755941.0 for Q1 2026, down 70.84% year-over-year from $2.6 million in Q1 2025, and up 142.94% quarter-over-quarter from -$1.8 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Change in Cash (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Change in Cash history runs 6 years deep, the most recent figure standing at $755941.0 for Q1 2026.
- In Q1 2026, Change in Cash fell 70.84% year-over-year to $755941.0; the TTM figure through Mar 2026 stood at -$3.4 million (down 209.91% YoY), while the FY2025 annual figure was -$1.6 million, down 141.69% from the prior year.
- Change in Cash for Q1 2026 stood at $755941.0, up from -$1.8 million in the prior quarter.
- The five-year high for Change in Cash was $9.1 million in Q3 2022, with the low at -$2.7 million in Q3 2025.
- The 5-year median for Change in Cash is -$703034.0 (2024), against an average of $34423.4.
- The sharpest annual moves came in 2023 and 2025: Change in Cash slumped 1161.92% in 2023, then soared 320.11% in 2025.
- Shuttle Pharmaceuticals Holdings' Change in Cash stood at -$703187.0 in 2022, then plunged by 86.24% to -$1.3 million in 2023, then jumped by 234.66% to $1.8 million in 2024, then plunged by 199.84% to -$1.8 million in 2025, then jumped by 142.94% to $755941.0 in 2026.
- Business Quant data shows SHPH's Change in Cash at $755941.0 in Q1 2026, -$1.8 million in Q4 2025, and -$2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | 755,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,941.00 |
| Dec 31, 2025 | -1.76 Mn |
| Sep 30, 2025 | -2.72 Mn |
| Jun 30, 2025 | 305,065.00 |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | -538,938.00 |
| Jun 30, 2024 | -703,034.00 |
| Mar 31, 2024 | -1.18 Mn |
| Dec 31, 2023 | -1.31 Mn |
| Sep 30, 2023 | -1.56 Mn |
| Jun 30, 2023 | -1.72 Mn |
| Mar 31, 2023 | -1.25 Mn |
| Dec 31, 2022 | -703,187.00 |
| Sep 30, 2022 | 9.07 Mn |
| Jun 30, 2022 | -355,420.00 |
| Mar 31, 2022 | -98,892.00 |
| Dec 31, 2021 | 359,774.00 |